The results showed that the functional prognosis of AIS patients may have a trend relationship with the quartile of serum PON1 activity: the average mRS score of AIS patients at 3 months was lower with the increase of serum PON1 activity (p = 0.007). Here, PON1 is linked to androgen insensitivity syndrome.